KRYSTAL LEACH: Open Payments
NPI 1245965664 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 26 payments from 8 companies in 2025. Trend: 2023 $332 · 2024 $237 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $120 |
| ABBVIE INC. | 6 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
Products named: REXULTI, TRINTELLIX, VRAYLAR, INGREZZA, CAPLYTA, IMBRUVICA, Qelbree, LYBALVI.
Industry payments across PA — which companies pay providers there.
